{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T04:00:07Z","timestamp":1785384007138,"version":"3.55.0"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008975","name":"Universitat de les Illes Balears","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008975","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology Case Reports"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.eucr.2026.103513","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T06:42:58Z","timestamp":1781678578000},"page":"103513","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Mesalazine-induced nephrolitiasis and crystalluria"],"prefix":"10.1016","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8814-900X","authenticated-orcid":false,"given":"Rafel M.","family":"Prieto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Juli\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flor A.","family":"Ordo\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Costa-Bauz\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Cabeza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Grases","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.eucr.2026.103513_bib1","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1053\/j.ajkd.2017.05.013","article-title":"Sulfasalazine-induced crystalluria causing severe acute kidney injury","volume":"70","author":"Durando","year":"2017","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.eucr.2026.103513_bib2","first-page":"41","article-title":"[Drug-induced bilateral nephrolithiasis in an ulcerative colitis patient: a case report] Japanese","volume":"110","author":"Ogawa","year":"2019","journal-title":"Nihon Hinyokika Gakkai Zasshi"},{"issue":"6","key":"10.1016\/j.eucr.2026.103513_bib3","first-page":"561","article-title":"Nefrolitiasis por Mesalazina [Mesalazine renal lithiasis]","volume":"73","author":"V\u00edlchez","year":"2020","journal-title":"Arch Esp Urol"},{"issue":"4","key":"10.1016\/j.eucr.2026.103513_bib4","first-page":"496","article-title":"Papel del laboratorio cl\u00ednico en el estudio de nefrolitiasis y cristaluria por mesalazina","volume":"6","author":"Balbuena","year":"2025","journal-title":"Adv Lab Med"},{"issue":"3","key":"10.1016\/j.eucr.2026.103513_bib5","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00240-013-0553-z","article-title":"Mesalamine: a rare constituent of urinary tract concretions","volume":"41","author":"Hasan","year":"2013","journal-title":"Urolithiasis"},{"issue":"6","key":"10.1016\/j.eucr.2026.103513_bib6","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/j.xphs.2018.02.016","article-title":"A biopredictive in vitro comparison of oral locally acting mesalazine formulations by a novel dissolution model for assessing intraluminal drug release in individual subjects","volume":"107","author":"Karkossa","year":"2018","journal-title":"J Pharm Sci"},{"issue":"12","key":"10.1016\/j.eucr.2026.103513_bib7","first-page":"1365","article-title":"Diagnosis and management of Crohn\u2019s disease","volume":"84","author":"Wilkins","year":"2011","journal-title":"Am Fam Physician"},{"issue":"S1","key":"10.1016\/j.eucr.2026.103513_bib8","doi-asserted-by":"crossref","first-page":"295","DOI":"10.5802\/crchim.109","article-title":"Drug-induced nephrolithiasis and crystalluria: the particular case of the sulfasalazine derivatives","volume":"25","author":"Chebion","year":"2022","journal-title":"C R Chim"},{"issue":"8","key":"10.1016\/j.eucr.2026.103513_bib9","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.14309\/ajg.0000000000000311","article-title":"Mesalazine and nephrolithiasis: leave no stone unturned","volume":"114","author":"Simsek","year":"2019","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.eucr.2026.103513_bib10","first-page":"132","article-title":"Mesalazine: a novel etiology for drug-induced urinary calculi","volume":"15","author":"Corbery","year":"2018","journal-title":"Urol J"},{"key":"10.1016\/j.eucr.2026.103513_bib11","doi-asserted-by":"crossref","first-page":"551","DOI":"10.12659\/AJCR.889719","article-title":"Mesalazine-induced renal calculi","volume":"14","author":"Jacobsson","year":"2013","journal-title":"Am J Case Rep"}],"container-title":["Urology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214442026001762?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214442026001762?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T03:37:30Z","timestamp":1785382650000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214442026001762"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":11,"alternative-id":["S2214442026001762"],"URL":"https:\/\/doi.org\/10.1016\/j.eucr.2026.103513","relation":{},"ISSN":["2214-4420"],"issn-type":[{"value":"2214-4420","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mesalazine-induced nephrolitiasis and crystalluria","name":"articletitle","label":"Article Title"},{"value":"Urology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eucr.2026.103513","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103513"}}